“An increasing number of patient[s] . . . in recent years have complained of early failure rates and side-effects after receiving transvaginal mesh, which is intended to help support the pelvic organs following surgical treatment of POP or SUI. The results of a study published in the May 15 edition of The Journal of the American Medical Association seem to confirm that vaginal mesh has a high risk of erosion that can lead to organ perforation and other complications, as well as necessitate revision surgery.”
HB Litigation Conferences Presents
Mass Tort Med School*
May 6-8, 2015
Boca Raton, Florida
*Plus three companion seminars on trial techniques and law firm marketing!